Jul 13, 2023Arbitration Confirms NovelStem Joint Venture’s Rights to Exploit‘Tom Clancy’s Net Force’ Franchise
May 15, 2023NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports...
Dec 14, 2022NovelStem’s Affiliate NewStem Announced New Collaboration to Validate its Software Diagnostic Device
Oct 13, 2022NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding...
Apr 11, 2022NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary